TITLE

Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: An explant model

AUTHOR(S)
Tan, Lorwai; Rogers, Trisha J.; Hatzirodos, Nick; Baker, Leonie M.; Enghooi Ooi; Wormald, Peter-John
PUB. DATE
March 2009
SOURCE
American Journal of Rhinology & Allergy;Mar2009, Vol. 23 Issue 2, p123
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The use of cytosine-phosphate-guanosine-oligodeoxynucleotides (CpG-ODNs) or immunostimulatory sequences (ISSs) in the treatment of airway diseases is gaining interest. Binding of the CpG-ODN ligand to Toll-like receptor 9 (TLR9) triggers a shift from a Th2- to a Th1-type response in the target tissue. In this study, we explored the potential use of CpG-ODN to dampen the predominantly Th2-driven chronic inflammatory state in our cohort of patients. Methods: An in vitro explant model comprising of sinonasal tissue from patients with asthma (n = 12) and without asthma (n = 11) were stimulated with CpG-ODN or Staphylococcus aureus enterotoxin B (SEB) or CpG-ODN in combination with SEB for 48 hours. Ten of the 12 asthma patients had nasal polyps. RNA was extracted for multiplex real-time reverse transcription polymerase chain reaction analysis and the 2-delta deltaCT method used to determine interleukin (IL)-5, p35 IL-12, interferon (IFN) gamma, and TLR9 expression levels. Results: CpG-ODN significantly reduced IL-5 mRNA expression in patients without asthma (p = 0.0379) but not in the asthma-associated group. SEB alone caused an increase in IL-5 levels that could be dampened when CpG-ODN was added in combination with SEB. Significant differences in mean IL-5 expression levels between the asthmatic and nonasthmatic categories were detected (Welch t-test; **p = 0.0041). Asthmatic and nonasthmatic patients present as two distinct categories as reflected by significant differences in their IL-5 response to CpG-ODN (F = 11.93; ***p = 0.0008), SEB (F = 41.34; *p = 0.0476) and CpG-ODN with SEB (F = 13.2; *p = 0.0114). In contrast, no significant differences were observed in the expression levels of IL-12, IFN-gamma, and TLR9. Conclusion: Localized application of CpG-ODN on its own or in combination with SEB may potentially reduce the expression of the proinflammatory cytokine IL-5 in nonasthmatic patients and may be further developed as an immunotherapeutic agent.
ACCESSION #
48689080

 

Related Articles

  • Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Pearlman, Aaron N.; Chandra, Rakesh K.; Chang, Dennis; Conley, David B.; Tripathi-Peters, Anju; Grammer, Leslie C.; Schleimer, Robert T.; Kern, Robert C. // American Journal of Rhinology & Allergy;Mar2009, Vol. 23 Issue 2, p145 

    Background: The effect of comorbid conditions such as asthma and atopy on the severity of chronic rhinosinusitis (CRS) and the presence of nasal polyps (NPs) remains an area of investigation. We sought to elucidate the relationship among these entities. Methods: The study population included 106...

  • The upper and lower airways: The epidemiological and pathophysiological connection. Slavin, Raymond G. // Allergy & Asthma Proceedings;Nov/Dec2008, Vol. 29 Issue 6, p553 

    The upper and lower airways do not exist as anatomically and functionally distinct areas. There are important relationships between both the nose and the paranasal sinuses and asthma. Both allergic rhinitis and rhinosinusitis may impact bronchial asthma. The patient with rhinitis should be...

  • Effect of tumor suppressor PTEN gene on apoptosis and cell cycle of human airway smooth muscle cells. Luo, Liang; Gong, Yuan; Qi, XieFei; Lai, WenYan; Lan, Haibing; Luo, Yaling // Molecular & Cellular Biochemistry;Apr2013, Vol. 375 Issue 1/2, p1 

    It is well established that hyperplasia and decreased apoptosis of airway smooth muscle cells (ASMCs) play an important role in the asthmatic airway remodeling. Tumor suppressor PTEN gene with phosphatase activity plays an important regulatory role in embryonic development, cell proliferation,...

  • 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis. Sudhoff, Holger; Klenke, Christin; Greiner, Johannes F. W.; Müller, Janine; Brotzmann, Viktoria; Ebmeyer, Jörg; Kaltschmidt, Barbara; Kaltschmidt, Christian // PLoS ONE;7/24/2015, Vol. 10 Issue 7, p1 

    Inflammatory diseases of the respiratory system such as rhinosinusitis, chronic obstructive pulmonary disease, or bronchial asthma are strongly associated with overproduction and hypersecretion of mucus lining the epithelial airway surface. 1,8-cineol, the active ingredient of the pharmaceutical...

  • Chronic Rhino-Sinusitis and Asthma: Concept of Unified Airway Disease (UAD) and its Impact in Otolaryngology. Meena, Rakesh; Meena, Deepali; Aseri, Yogesh; Singh, B.; Verma, P. // Indian Journal of Otolaryngology & Head & Neck Surgery;Aug2013 Supplement, Vol. 65, p338 

    The aim of our study is to understand the concept of unified airway disease, to know the advantage of this concept in the diagnosis and treatment of allergic rhinitis, chronic rhino-sinusitis and asthma, to know its impact on practice of otolaryngologists, to motivate the otorhinolaryngologist...

  • Die chronische Rhinosinusitis bei Morbus Widal: Krankheitsbild und Therapiem�glichkeiten. Jung, H. // Praxis (16618157);11/18/2009, Vol. 98 Issue 23, p1361 

    Chronic rhinosinusitis is often associated with bronchial asthma. If it's joined by intolerance to analgetics we call it Morbus Widal or Samters Trias. Especially chronic rhinosinusitis is often difficult to treat in these patients. Mostly the patients suffer a lot from nasal symptoms. This...

  • Aspirin-sensitive asthma and upper airway diseases. Chang, Jinny E.; Chin, William; Simon, Ronald // American Journal of Rhinology & Allergy;Jan/Feb2012, Vol. 26 Issue 1, p27 

    Background: Aspirin exacerbated respiratory disease (AERD) consists of nasal polyposis, rhinosinusitis, asthma, and aspirin (ASA) sensitivity. Objective: This article details how to diagnose and treat AERD and describes the procedures associated with ASA challenge and desensitization, benefits...

  • Association between severity of asthma and degree of chronic rhinosinusitis. Lin, David C.; Chandra, Rakesh K.; Tan, Bruce K.; Zirkle, Whitney; Conley, David B.; Grammer, Leslie C.; Kern, Robert C.; Schleimer, Robert P.; Peters, Anju T. // American Journal of Rhinology & Allergy;Jul/Aug2011, Vol. 25 Issue 4, p205 

    Background: There is a clinical association between asthma and chronic rhinosinusitis (CRS). This study was designed to determine whether severity of coexistent asthma affects the clinical presentation of CRS. Methods: Cross-sectional analysis was performed of prospectively collected data in 187...

  • Olfactory dysfunction and asthma as risk factors for poor quality of life in upper airway diseases. Katotomichelakis, Michael; Simopoulos, Efthimios; Zhang, Nan; Tripsianis, Gregory; Danielides, Gerasimos; Livaditis, Miltos; Bachert, Claus; Danielides, Vassilios // American Journal of Rhinology & Allergy;Jul/Aug2013, Vol. 27 Issue 4, p293 

    Background: The study of olfaction/quality of life (QoL) interaction has not been adequately discussed and remains to be further explored. Determination of clinical predictors for poor QoL may support consultation of respective patients. This study explores QoL of patients with olfactory...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics